- Home
- ANGO vs CLPT Comparison
ANGO vs CLPT Comparison
Compare ANGO & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANGO
- CLPT
- Stock Information
- Founded
- ANGO 1988
- CLPT 1998
- Country
- ANGO United States
- CLPT United States
- Employees
- ANGO N/A
- CLPT N/A
- Industry
- ANGO Medical/Dental Instruments
- CLPT Medical/Dental Instruments
- Sector
- ANGO Health Care
- CLPT Health Care
- Exchange
- ANGO Nasdaq
- CLPT Nasdaq
- Market Cap
- ANGO 439.5M
- CLPT 411.3M
- IPO Year
- ANGO 2004
- CLPT N/A
- Fundamental
- Price
- ANGO $9.11
- CLPT $14.11
- Analyst Decision
- ANGO Strong Buy
- CLPT Strong Buy
- Analyst Count
- ANGO 2
- CLPT 3
- Target Price
- ANGO $14.00
- CLPT $25.00
- AVG Volume (30 Days)
- ANGO 326.7K
- CLPT 225.1K
- Earning Date
- ANGO 04-02-2025
- CLPT 05-13-2025
- Dividend Yield
- ANGO N/A
- CLPT N/A
- EPS Growth
- ANGO N/A
- CLPT N/A
- EPS
- ANGO N/A
- CLPT N/A
- Revenue
- ANGO $283,320,000.00
- CLPT $31,390,000.00
- Revenue This Year
- ANGO N/A
- CLPT $23.48
- Revenue Next Year
- ANGO $6.35
- CLPT $33.68
- P/E Ratio
- ANGO N/A
- CLPT N/A
- Revenue Growth
- ANGO N/A
- CLPT 31.04
- 52 Week Low
- ANGO $5.47
- CLPT $5.11
- 52 Week High
- ANGO $13.50
- CLPT $19.22
- Technical
- Relative Strength Index (RSI)
- ANGO 46.41
- CLPT 55.36
- Support Level
- ANGO $8.55
- CLPT $12.85
- Resistance Level
- ANGO $9.68
- CLPT $14.64
- Average True Range (ATR)
- ANGO 0.36
- CLPT 0.84
- MACD
- ANGO -0.02
- CLPT 0.06
- Stochastic Oscillator
- ANGO 46.28
- CLPT 57.60
About ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.
About CLPT ClearPoint Neuro Inc.
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, ClearPoint Disposables, ClearPoint Software, and ClearPoint Therapeutic Solutions.